Aristopin 0.01% Eye Drop contains atropine sulfate 0.1 mg/mL (0.01%) and is a low-dose ophthalmic preparation primarily used to help slow the progression of myopia (short-sightedness) in children. It may be considered for children aged 4–14 years when myopia is progressing, under the supervision of an eye specialist.
Atropine affects muscarinic receptors in the eye and is thought to influence mechanisms involved in ocular growth. Long-term treatment may help reduce the rate of increase in axial eye length and thereby slow myopia progression.
১০০% অরিজিনাল পণ্যের নিশ্চয়তা
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Aristopin 0.01% should be used under the supervision of an ophthalmologist, particularly during long-term treatment.
Regular eye examinations are recommended to monitor:
Use extra caution in children with Down syndrome, spastic paralysis, brain damage, or a previous severe systemic reaction to atropine, as increased sensitivity may occur.
The provided product information recommends that this preparation not be used in children younger than 4 years.
If too many drops are accidentally administered, seek medical advice promptly. In case of excessive exposure, rinse the eye with clean water if appropriate and obtain emergency medical assistance if symptoms develop.
Possible signs of atropine toxicity include:
Note: Higher-strength atropine ophthalmic preparations, such as 1%, have different uses, including pupil dilation and cycloplegia during eye examinations and management of certain inflammatory eye conditions. These indications should not be applied to the 0.01% preparation without medical advic
Atropine is an antimuscarinic medicine. Muscarinic receptors are present in several ocular tissues and are involved in processes related to eye growth and accommodation.
Low-dose atropine is believed to act on ocular muscarinic pathways, potentially involving receptors in the retina and sclera. These effects may influence cellular signaling and scleral remodeling, helping reduce excessive axial elongation of the eye and consequently slowing the progression of myopia.
The exact mechanism by which low-dose atropine controls myopia progression has not been fully established.
Children aged 4–14 years:
Instill 1 drop into each eye once daily at bedtime, or use exactly as prescribed by the ophthalmologist.
Treatment may need to continue for an extended period to obtain the intended benefit. Long-term treatment should be monitored regularly by an eye-care professional.
After applying the drop, gently close the eyes and apply light pressure over the tear duct near the inner corner of the eye for approximately 1 minute. This may help reduce systemic absorption.
Tell your doctor about all medicines the child is taking. Atropine may interact with medicines that have anticholinergic effects and certain ophthalmic or systemic medicines, including:
Aristopin 0.01% should not be used in patients with angle-closure glaucoma or when angle-closure glaucoma is suspected. Children who may be at risk of glaucoma should undergo appropriate eye assessment before treatment.
Do not use the medicine in individuals with known hypersensitivity to atropine or any component of the formulation.
Aristopin 0.01% is primarily intended for pediatric use. Atropine can be absorbed systemically following ocular administration, although the amount is expected to be small with ophthalmic use.
Systemically absorbed atropine can enter breast milk in very small amounts. Breastfeeding mothers should consult a healthcare professional before using atropine eye drops, particularly if prolonged treatment is required.
Store below 30°C in a dry place and protect from light. Keep out of the reach of children.
Do not allow the dropper tip to touch the eye, fingers, or other surfaces, as this may contaminate the preparation. Close the bottle tightly after each use and follow the manufacturer's instructions regarding how long the product may be used after opening.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.